148 related articles for article (PubMed ID: 6397292)
1. Multiple reactivities of cytotoxic monoclonal antibodies against pancreatic islet cells.
Suzuki M; Sharma B; Waldeck N; Charles MA
Diabetes Res; 1984 Nov; 1(4):179-81. PubMed ID: 6397292
[TBL] [Abstract][Full Text] [Related]
2. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
[TBL] [Abstract][Full Text] [Related]
3. Complement-dependent cytotoxicity of monoclonal antibodies against islet cells.
Witt S; Hehmke B; Dietz H; Ziegler B; Hildmann W; Ziegler M
Biomed Biochim Acta; 1985; 44(1):117-21. PubMed ID: 3888203
[TBL] [Abstract][Full Text] [Related]
4. Immunological events in new onset diabetes.
Charles M; Suzuki M; Sundsmo J; Waldeck N; Negishi K; Slater L; Ong K; Buckingham B; Kershnar A
Biomed Biochim Acta; 1984; 43(5):615-9. PubMed ID: 6383365
[TBL] [Abstract][Full Text] [Related]
5. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
[TBL] [Abstract][Full Text] [Related]
6. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
Kinouchi T; Bander NH; Kotake T
J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
[TBL] [Abstract][Full Text] [Related]
7. Immune islet killing mechanisms associated with insulin-dependent diabetes: three rabbit antibody-mediated islet cell cytotoxicity models.
Charles MA; Suzuki M; Slater L; Waldeck N; Ong K
Diabetologia; 1983 Oct; 25(4):348-54. PubMed ID: 6357917
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal islet cell surface antibody dependent cellular cytotoxicity mediated by rat splenocytes with the RIN cell line as target.
Hulinsky I; Ziegler B; Cabrera E; Schlosser M; Witt S; Ziegler M
Exp Clin Endocrinol; 1989 May; 93(2-3):181-6. PubMed ID: 2673812
[TBL] [Abstract][Full Text] [Related]
9. Absence of cytotoxicity of islet cell surface antibodies in vivo despite complement-mediated cytotoxic effects to islet cells in vitro.
Kohnert KD; Hehmke B; Fält K; Ziegler M
Biomed Biochim Acta; 1984; 43(5):663-73. PubMed ID: 6206850
[TBL] [Abstract][Full Text] [Related]
10. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
Batova A; Kamps A; Gillies SD; Reisfeld RA; Yu AL
Clin Cancer Res; 1999 Dec; 5(12):4259-63. PubMed ID: 10632368
[TBL] [Abstract][Full Text] [Related]
11. Effect of islet cell surface antibodies on neonatal rat pancreatic islet cells or isolated islets of Langerhans in vitro.
Schröder D; Hehmke B; Kohnert KD; Fiebach H; Jenssen HL; Besch W
Biomed Biochim Acta; 1985; 44(1):107-15. PubMed ID: 3888202
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies which react with lymphocyte-lysed target cells and which cross-react with complement-lysed ghosts.
Ward RH; Lachmann PJ
Immunology; 1985 Sep; 56(1):179-88. PubMed ID: 4043993
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody homodimers: enhanced antitumor activity in nude mice.
Wolff EA; Schreiber GJ; Cosand WL; Raff HV
Cancer Res; 1993 Jun; 53(11):2560-5. PubMed ID: 8495420
[TBL] [Abstract][Full Text] [Related]
14. Glutamate decarboxylase (GAD) is not detectable on the surface of rat islet cells examined by cytofluorometry and complement-dependent antibody-mediated cytotoxicity of monoclonal GAD antibodies.
Ziegler B; Augstein P; Schröder D; Mauch L; Hahmann J; Schlosser M; Ziegler M
Horm Metab Res; 1996 Jan; 28(1):11-5. PubMed ID: 8820987
[TBL] [Abstract][Full Text] [Related]
15. Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.
Guo B; Ma ZW; Li H; Xu GL; Zheng P; Zhu B; Wu YZ; Zou Q
Clin Immunol; 2008 Aug; 128(2):155-63. PubMed ID: 18502181
[TBL] [Abstract][Full Text] [Related]
16. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D
Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366
[TBL] [Abstract][Full Text] [Related]
17. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic effects of islet cell surface antibodies.
Hehmke B; Kohnert KD; Dietz H; Zühlke H
Acta Biol Med Ger; 1982; 41(12):1117-22. PubMed ID: 6765153
[TBL] [Abstract][Full Text] [Related]
19. Complement-mediated cytotoxic effects of islet cell surface antibodies: factors influencing the sensitivity of the target cells.
Jahr H; Kruschel B; Walter BM; Kohnert KD
Biomed Biochim Acta; 1984; 43(5):641-6. PubMed ID: 6383368
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
